BREAKING NEWS

US Food and Drug Administration approves Teva leukemia drug

By REUTERS

OCTOBER 26, 2012 17:20

The US Food and Drug Administration on Friday said it has approved a new leukemia treatment from Israel-headquartered Teva Pharmaceutical Industries Ltd to be sold under the brand name Synribo.

The drug, also known as omacetaxine mepesuccinate, is approved to treat a type of the blood and bone marrow cancer called chronic myelogenous leukemia, or CML, in patients whose cancer has progressed after treatment with at least two drugs from a class called tyrosine kinase inhibitors.

"Today's approval provides a new treatment option for patients who are resistant to or cannot tolerate other FDA-approved drugs for chronic or accelerated phases of CML," Richard Pazdur, director of the Office of Hematology and Oncology Products in FDA's Center for Drug Evaluation and Research, said in a statement.

Boris Johnson, who introduced voter ID rule, forgets his while voting

By REUTERS

05/03/2024 12:13 AM

Dror Or killed on October 7, body taken by Hamas - Kibbutz Be'eri

By JERUSALEM POST STAFF

05/03/2024 12:08 AM

US says Israel should prevent attacks on aid convoys, Hamas can't divert

By REUTERS

05/02/2024 09:01 PM

Health Ministry announces measles case in Haifa

By DR. ITAI GAL

05/02/2024 08:30 PM